Alpha Paradigm Partners’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$474K Buy
2022
Q3
$279K Buy
2022
Q2
Sell
2022
Q1
$494K Buy
2021
Q4
$113K Buy